Stock Taper
RVTY
REVVITY, INC.
NYSE
$128.67
▼ DOWN 0.10% (-0.13)

KEY STATISTICS

Market Cap$14.35 B
52w High$130.07
52w Low$81.22
Dividend Yield0.24%
FrequencyQuarterly
P/E24.05
Volume1.63M
Shares Out.111.56M

COMPANY

LEADERSHIP

Prahlad R. Singh
CHIEF EXECUTIVE
Prahlad R. Singh

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 6, 1965
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
11,000

PRICE TARGET

Target High$125.00
Target Low$95.00
Target Median$115.00
Target Consensus$110.40

UPCOMING EARNINGS

DateOct 26, 2026
DayMonday
Rev. Est.$694.07M
OCT
26
MON

SPLIT RECORD

DATETYPERATIO
2001-06-04Forward2:1
1992-05-11Forward2:1
1982-02-02Forward2:1
1980-02-04Forward2:1

PRICE

$128.67 ▼ DOWN 0.10% (−$0.13)
OVERLAYS
$127$128$1289:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM128.67

About Revvity, Inc.

https://www.revvity.com ↗

Revvity, Inc. provides global diagnostic, life sciences, and applied solutions—including instruments, reagents, and services—for research, health screening, environmental analysis, and industrial applications across various markets.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT REVVITY, INC. IS KNOWN FOR

Opera Phenix OptIQ™ high-content screening system
Opera Phenix OptIQ™ high-content screening system

A high-content screening system that accelerates phenotypic screening and cellular analysis by enabling quantitative imaging of complex models like 3D organoids and organ-on-chip, streamlining high-throughput drug discovery.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Diagnostics$356.13M $390.07M $349.27M $370.99M
Life Sciences$342.82M $381.99M $361.85M $358.7M

Revenue by Geography

MapREGIONQ2-2025Q3-2025Q1-2026Q2-2026
Americas$323.58M $307.28M $315.99M $325.58M
Europe$203.63M $202.4M $223.05M $229.04M
Asia$193.07M $189.28M $172.08M $175.06M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity3
Return On Assets3
Debt To Equity2
Price To Earnings1
Price To Book3
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Purchase
2026-05-04
Ro Khanna
Ro Khanna
Purchase
2025-09-29
Lisa McClain
Lisa McClain
Sale (Partial)
2025-07-22
Rob Bresnahan
Rob Bresnahan
Sale (Full)
2025-04-08

INSIDER TRADES

DIRECTOR
MICHAS ALEXIS P
Sale · 285 shares
2026-08-25
OFFICER: PLEASE SEE REMARKS
Goldberg Joel S
Purchase · 27.8K shares
2026-08-14
DIRECTOR, OFFICER: PLEASE SEE REMARKS
Singh Prahlad R.
Purchase · 59.6K shares
2026-08-13
DIRECTOR, OFFICER: PLEASE SEE REMARKS
Singh Prahlad R.
Sale · 7.6K shares
2026-08-13

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OUTPERFORM 2
EQUAL WEIGHT 2
NEUTRAL 2
BUY 2
HOLD 2
10 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
GH$158.63COMPARE
SOLV$91.34COMPARE
CRL$287.57COMPARE
ICLR$165.05COMPARE
ALGN$158.78COMPARE
RDY$12.16COMPARE
ENSG$171.19COMPARE
QGEN$43.42COMPARE